Stock futures are little changed after S&P 500 posts first winning session in three: Live updates

Stock futures are little changed after S&P 500 posts first winning session in three: Live updates


Traders work on the floor of the New York Stock Exchange on July 08, 2025 in New York City.

Michael M. Santiago | Getty Images

Stock futures were relatively unchanged on Wednesday evening after the S&P 500 recouped some of its losses from this week’s tariff-fueled slide.

S&P 500 futures traded just above the flatline, along with Nasdaq 100 futures. Futures tied to the Dow Jones Industrial Average were also flat.

President Donald Trump announced late Wednesday a 50% tariff on Brazil partly in retaliation for the current trial against former Brazilian President Jair Bolsonaro for his role in an alleged attempt to overturn the country’s 2022 election results. The move was also due to the “very unfair trade relationship” with Brazil, Trump added, saying it has been “far from Reciprocal.”

That comes after Wall Street saw gains during Wednesday’s session. The S&P 500 and Dow Jones Industrial Average posted their first positive sessions in three with a rise of 0.6% and 0.5%, respectively, while the Nasdaq Composite jumped 0.9%, closing at a record high. Those gains were spurred by optimism around the artificial intelligence trade, which sent Nvidia shares nearly 2% higher to briefly become the first public company to be valued at $4 trillion.

The bullish AI sentiment helped lift stocks as investors moved past the latest developments surrounding Trump’s tariffs. Prior to the president’s announcement of levies on Brazil, he sent letters that dictated new U.S. rates on the imports of at least seven additional countries. He had also sent letters laying out new rates earlier this week to the leaders of 14 other countries, such as Japan and South Korea. The duties are set to take effect Aug. 1.

“AI might be exactly what is needed to counteract any price increases from the tariffs,” said Jeremy Siegel, Wharton School professor of finance and Wisdom Tree chief economist, on CNBC’s “Closing Bell” Wednesday.

“If we don’t hear much bad effects, boy, this bull market certainly, I think, has further to run,” Siegel also said. “If we begin to hear … there’s some hurdles that are harder to overcome, then we’re going to see choppiness, I think, this quarter.”

Concerns over the impact of tariffs, specifically as it relates to inflation and the labor market, also came up in the minutes from the Federal Reserve’s June meeting unveiled Wednesday. However, the minutes showed that policymakers were split on how many interest rate cuts the central bank should make over the coming months.

Investors are awaiting more developments on the economic front, as jobless claims data for the week ending July 5 is due out Thursday morning. Economists polled by Dow Jones are expecting an increase of 2,000 to 235,000 from the previous week.



Source

We spoke to over 30 CEOs and business leaders. Here’s what worries them most
World

We spoke to over 30 CEOs and business leaders. Here’s what worries them most

Business leaders are confronting a new operating reality: one where war, inflation, AI and supply chain shocks are no longer exceptional events, but part of the baseline. CNBC spoke to more than 30 CEOs, business executives and industry leaders at the annual Converge Live event in Singapore last week. Across sectors — banking, energy, shipping, […]

Read More
U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets
World

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 16, 2026. Jeenah Moon | Reuters Global markets are entering the week balancing resilient risk appetite against renewed geopolitical strain as prospects of U.S.-Iran negotiations took a hit over the weekend. U.S. President Donald Trump scrapped […]

Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in .75 billion deal
World

Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]

Read More